Business Description
Mydecine Innovations Group Inc
NAICS : 325411
SIC : 3741
ISIN : CA64157D1087
Compare
Compare
Traded in other countries / regions
MYCO.Canada0NF0.GermanyMYCOF.USAMYIG.UK IPO Date
2015-02-23Description
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -1.46 | |||||
| Debt-to-Equity | -0.84 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 66 | |||||
| 3-Year EPS without NRI Growth Rate | 43.8 | |||||
| 3-Year FCF Growth Rate | 34.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.34 | |||||
| 9-Day RSI | 52.17 | |||||
| 14-Day RSI | 50.97 | |||||
| 6-1 Month Momentum % | -99.9 | |||||
| 12-1 Month Momentum % | -99.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.71 | |||||
| Quick Ratio | 0.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -181.4 | |||||
| Shareholder Yield % | -727.63 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -591.31 | |||||
| ROIC % | -2990.05 | |||||
| ROC (Joel Greenblatt) % | -14061.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.25 | |||||
| EV-to-EBITDA | -0.25 | |||||
| EV-to-Forward-Revenue | 0.74 | |||||
| EV-to-FCF | -0.98 | |||||
| Earnings Yield (Greenblatt) % | -400 | |||||
| FCF Yield % | -408.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MYCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mydecine Innovations Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.536 | ||
| Beta | 1.06 | ||
| Volatility % | 120.2 | ||
| 14-Day RSI | 50.97 | ||
| 14-Day ATR ($) | 0.005392 | ||
| 20-Day SMA ($) | 0.012431 | ||
| 12-1 Month Momentum % | -99.97 | ||
| 52-Week Range ($) | 0.0001 - 0.2929 | ||
| Shares Outstanding (Mil) | 52.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mydecine Innovations Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mydecine Innovations Group Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mydecine Innovations Group Inc Frequently Asked Questions
What is Mydecine Innovations Group Inc(MYCOF)'s stock price today?
The current price of MYCOF is $0.02. The 52 week high of MYCOF is $0.29 and 52 week low is $0.00.
When is next earnings date of Mydecine Innovations Group Inc(MYCOF)?
The next earnings date of Mydecine Innovations Group Inc(MYCOF) is .
Does Mydecine Innovations Group Inc(MYCOF) pay dividends? If so, how much?
Mydecine Innovations Group Inc(MYCOF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers